Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

TPEX/7888 stock hub

TPEX/7888 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/7888is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/7888
In the news

Latest news · TPEX/7888

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-39
P25 n/aP50 n/aP75 n/a
ROIC-25.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/7888 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
124
Groups with data
10
Currency
TWD
Showing 124 of 124 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
Taiwan
Country code
TW
Employees
31
Employees Change
11%
Employees Change Percent
55
Enterprise value
TWD 2.2B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
TWD 3B
Price
TWD 40
Price currency
TWD
Sic
2834
Symbol
tpex/7888
Website
https://libopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-9.85%
EV Earnings
-7.46x
EV/FCF
-6.32x
FCF yield
-11.62%
P/B ratio
2.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

6
MetricValue
Net Income
TWD -296.3M
Profit Per Employee
TWD -9.6M
ROA
-24.86
ROCE
-29.06
ROE
-39.01
ROIC
-25.3

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
TWD 1.1B
Cash
TWD 801M
Current Assets
TWD 927M
Current Liabilities
TWD 21.5M
Debt
TWD 1.3M
Debt Equity
TWD 0
Debt FCF
TWD -0
Equity
TWD 1.1B
Interest Coverage
-7,708.1
Liabilities
TWD 21.5M
Long Term Assets
TWD 155.4M
Long Term Liabilities
TWD 0
Net Cash
TWD 799.7M
Net Cash By Market Cap
TWD 26.57
Net Cash Growth
193.53%
Net Debt Equity
TWD -0.75
Tangible Book Value
TWD 912.4M
Tangible Book Value Per Share
TWD 12.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
43.19
Net Working Capital
TWD 105.8M
Quick ratio
37.4
Working Capital
TWD 905.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-33.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

28
MetricValue
50-day SMA
44.78
All Time High
69
All Time High Change
-42.03%
All Time High Date
2026-01-08
All Time Low
39
All Time Low Change
2.56%
All Time Low Date
2026-05-07
ATR
1.18
Beta1y
0.56
Ch YTD
-18.7
High
40.5
High52
69
High52 Date
2026-01-08
High52ch
-42.03%
Low
39.05
Low52
39
Low52 Date
2026-05-07
Low52ch
2.56%
Ma50ch
-10.68%
RSI
32.48
RSI Monthly
0
RSI Weekly
45.59
Sharpe ratio
-0.53x
Sortino ratio
-0.9
Total Return
-33.57%
Tr YTD
-18.7
Tr1m
-14.16%
Tr3m
-20%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
TWD -308.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
61,690,070%
Net Borrowing
-1,655,000
Shares Insiders
7.18%
Shares Out
75,235,000
Shares Qo Q
104.18%
Shares Yo Y
33.57%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

38
MetricValue
Adjusted FCF
TWD -371.3M
Average Volume
41,135.3x
Bv Per Share
14.1
CAPEX
TWD -558,000
Ch1m
-14.16
Ch3m
-20
Change
1.01%
Change From Open
0.25
Close
39.6
Days Gap
0.76
Depreciation Amortization
21,677,000
Dollar Volume
1,497,920
Earnings Date
2026-06-18
EBIT
TWD -308.3M
EBITDA
TWD -286.6M
EPS
TWD -4.74
F Score
1
FCF
TWD -349.7M
FCF EV Yield
-15.82x
FCF Per Share
TWD -4.65
Financing CF
875,671,000
Fiscal Year End
December
Founded
2,017
Investing CF
-969,000
Is Primary Listing
1
Last Report Date
2025-12-31
Ma20
41.68
Ma20ch
-4.03%
Net CF
525,601,000
Next Earnings Date
2026-06-18
Open
39.9
Position In Range
65.52
Ppne
2,844,000
Price Date
2026-05-08
Ptbv Ratio
3.3
Relative Volume
0.91x
Share Based Comp
21,607,000
Volume
37,448
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/7888 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns TPEX/7888?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+7.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+33.6%
Negative means the company is buying back shares.
Technical

TPEX/7888 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
32.5
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.53
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/7888

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7888 stock rating?

tpex/7888 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7888 analysis?

The full report lives at /stocks/tpex/7888/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7888?

The latest report frames tpex/7888 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7888 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tpex/7888 stock profile: metrics, valuation and analysis | เอเจนต์ AI ตลาดหุ้น